AI brief of an SEC Form 8-K · IDEX (IEX)

IDEX cuts 2025 EPS outlook as Q2 sales rise 7% and GAAP EPS falls 6%

Mixed Impact 4 of 5 guidance Written later

IDEX reported second quarter 2025 net sales of $865.4 million, up 7% from a year earlier and 1% organically, while GAAP diluted EPS fell to $1.74 from $1.86. The company lowered its full-year 2025 GAAP diluted EPS guidance to $6.30 to $6.44 from $6.56 to $6.95, citing customers taking a more cautious stance on larger orders, which matters to shareholders because it reduces expected full-year earnings.

Key points

  • Q2 net sales were $865.4 million, up 7% reported and 1% organic; Mott acquisition drove most of the increase.
  • GAAP diluted EPS was $1.74 versus $1.86; adjusted diluted EPS was $2.07 versus $2.06.
  • Full-year 2025 adjusted diluted EPS guidance was lowered to $7.85 to $7.95 from $8.10 to $8.45.
  • Third quarter 2025 GAAP diluted EPS is expected at $1.54 to $1.61, based on 2% to 3% organic sales growth.

The filing

CompanyIDEX (IEX)
Form8-K, current report
Filed with the SECJul 30, 2025, 7:00 AM ET
Accession number0000832101-25-000030

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:11 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 30, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.